SMTL ID : 2anw.1

Expression, crystallization and three-dimensional structure of the catalytic domain of human plasma kallikrein: Implications for structure-based design of protease inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x BEN: BENZAMIDINE(Non-functional Binders)

BEN.1: 14 residues within 4Å: Chain A: D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, G.211, C.212, A.213, G.219, V.220 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:T.206 Hydrogen bonds: A:D.182, A:D.182 Water bridges: A:W.208, A:E.210

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tang, J. et al., Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein. J.Biol.Chem. (2005)

Release Date

2005-10-11

Peptides

plasma kallikrein, light chain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

plasma kallikrein, light chain